Aim: To determine whether the flavonoid baicalin attenuates oxygen-glucose deprivation (OGD)-induced injury by inhibiting oxidative stress-mediated 5-lipoxygenase (5-LOX) activation in PC12 cells. Methods: The effects of baicalin and the 5-LOX inhibitor zileuton on the changes induced by OGD/recovery or H 2 O 2 (an exogenous reactive oxygen species [ROS]) in green fluorescent protein-5-LOX-transfected PC12 cells were compared. Results: Both baicalin and zileuton attenuated OGD/recovery-and H 2 O 2 -induced injury and inhibited OGD/recovery-induced production of 5-LOX metabolites (cysteinyl leukotrienes) in a concentration-dependent manner. However, baicalin did not reduce baseline cysteinyl leukotriene levels. Baicalin also reduced OGD/recovery-induced ROS production and inhibited 5-LOX translocation to the nuclear envelope and p38 phosphorylation induced by OGD/recovery and H 2 O 2 . In contrast, zileuton did not show these effects. Conclusion: Baicalin can inhibit 5-LOX activation after ischemic injury, which may partly result from inhibition of the ROS/p38 mitogenactivated protein kinase pathway.
Introduction 5-Lipoxygenase (5-LOX, EC 1.13.11.34) is a key enzyme in catalyzing the conversion of arachidonic acid to its metabolites, including leukotriene B 4 (LTB 4 ), cysteinyl leukotrienes (CysLTs, namely LTC 4 , LTD 4 , and LTE 4 ) and 5S-hydroxy-6,8,11,14-eicosatetraenoic acid (5-HETE) [1, 2] . 5-LOX is distributed in the cytosol, nucleus, or both in resting cells depending on the cell type [2, 3] . When cells are stimulated, 5-LOX is translocated from the intracellular pool to the nuclear envelope where it interacts with its co-factors, 5-LOX activating protein (FLAP) and phospholipase A 2 , to form an active complex for metabolite production [3] . Therefore, as one of the characteristics of 5-LOX activation, its translocation to the nuclear envelope is critical for its enzymatic activation and is a target for antiinflammatory 5-LOX inhibitors [3] . 5-LOX metabolites play an important role in inflammatory diseases of the peripheral tissues and the central nervous system, such as bronchial asthma [4, 5] and ischemic brain injury [6] [7] [8] [9] . In these diseases, various stimuli activate 5-LOX through two main ways. Specifically, elevation of intracellular calcium that generally occurs after excitotoxicity and mitogen-activated protein kinase (MAPK)-regulated phosphorylation that can be induced by oxidative stress [3] both activate 5-LOX. Previously, we reported that 5-LOX can be activated after ischemic brain injury in rats [8, 10] , after oxygen-glucose deprivation (OGD)-induced ischemic injury in cultured neurons and in pheochromocytoma (PC12) cells [11] [12] [13] [14] . In primary neuron cultures, OGD induces release of excitatory amino acids that activate NMDA receptors to elevate intracellular calcium, resulting in 5-LOX translocation to the nuclear envelope and activation of 5-LOX to produce CysLTs [12] . Calcium-dependent 5-LOX activation is also found in PC12 cells after exposure to NMDA [15] . In addition, we recently found oxidative stress-induced 5-LOX activation in ischemic PC12 cells. OGD increases the release of reactive oxygen species (ROS), which activate 5-LOX through the p38 MAPK pathway [14] . Therefore, ischemic 5-LOX activation can be regulated by both elevated intracellular calcium after excitotoxicity and the activated MAPK pathway after oxidative stress. Baicalin is one of the predominant flavonoids isolated from the dry roots of Scutellaria baicalensis Georgi (Huang Qin) with multiple pharmacological effects in peripheral organs and tissues [16] [17] [18] [19] . Baicalin also exerts a protective effect on ischemic brain injury [20] [21] [22] [23] . Previously, we reported that baicalin attenuates in vitro ischemic-like injury in rat primary cortical neurons [13] and hippocampal slices [24] , and this effect partly relates to the inhibition of NMDA receptor-mediated 5-LOX activation in the neurons [13] . Thus, baicalin can inhibit ischemic 5-LOX activation induced by excitotoxicity; however, whether it also inhibits oxidative stress-induced 5-LOX activation is unknown. Therefore, to determine whether baicalin can inhibit oxidative stressinduced 5-LOX activation, we investigated the effect of baicalin on the changes induced by OGD and hydrogen peroxide (H 2 O 2 , an exogenous ROS) in green fluorescent protein (GFP)-5-LOX-transfected PC12 cells. To clarify the properties of 5-LOX inhibition, we compared the effects of baicalin and the 5-LOX inhibitor zileuton, an iron-ligand inhibitor, on these cells following OGD [25, 26] .
Materials and methods

Materials
Dulbecco's modified Eagle's medium (DMEM) and horse serum were purchased from Gibco (Carlsbad USA). Fetal bovine serum (FBS) was obtained from Sijiqing Biol Inc.
(Hangzhou, China). The polyclonal antibody against 5-LOX and CysLT enzyme immunoassay (EIA) kit were purchased from Cayman Chemicals (Ann Arbor, MI, USA). The monoclonal antibody against phosphorylated p38 and the polyclonal antibody against p38 were obtained from Santa Cruz Biotechnology Inc (Santa Cruz, USA). 3-(4,5-dimethyml-2-thiazolyl)-2,5-diphenyl-2H-tetraxolium bromide (MTT), 2,7-dichlorofluorescin diacetate (DCF-DA), baicalin, and H 2 O 2 were purchased from Sigma-Aldrich (St Louis, USA) and zileuton from Gaomeng Pharmaceutical Co (Beijing, China).
Cell culture and 5-LOX transfection PC12 cells were purchased from the Institute of Cell Biology at the Chinese Academy of Sciences (Shanghai, China) and maintained at 37 °C in a humidified incubator containing 5% CO 2 in high-glucose DMEM supplemented with 10% heat-inactivated horse serum, 5% FBS, 100 U/mL penicillin and 100 µg/mL streptomycin.
The pEGFP-C2/5-LOX (GFP-5-LOX) and pEGFP-C2 null vectors (gifts from Professor Funk CD, University of Pennsylvania, USA [now in Queen's University, Canada]) were transfected into PC12 cells as we recently reported [14] . PC12 cell lines stably expressing GFP or GFP-5-LOX have been characterized by fluorescence microscopy and Western blot analysis [14] . To detect GFP-5-LOX translocation, the transfected cells cultured on glass slips were washed with phosphate buffered saline (PBS) and immediately fixed with 4% paraformaldehyde. Then the cells were observed under a fluorescence microscope (Olympus BX51, Tokyo, Japan).
OGD, H 2 O 2 and agent treatments PC12 cells were exposed to OGD as described pre viously [11, 12, 14] . Briefly, cells were rinsed twice and incubated in glucose-free Earle's solution. The cells were then introduced into an anaerobic chamber containing a mixture of 95% N 2 and 5% CO 2 at 37 °C for 2 h. This procedure decreased pO 2 in the solutions from 154.0±7.3 to 23.9±5.1 mmHg (mean±SD, n=5). At the end of 2-h OGD, the media were replaced and cells were cultured in normal condition for 0.5 h (for ROS measurement), 1.5 h (for p38 determination), 2 h (for 5-LOX translocation), 3 h (for measurement of CysLTs) or 24 h (for cell viability) of recovery, as previously reported [14] . H 2 O 2 was freshly prepared from an 8.8 mol/L stock solution before use, and PC12 cells were treated with H 2 O 2 160 µmol/L for 20 min (for p38 determination), 40 min (for 5-LOX translocation) or 24 h (for cell viability) at 37 °C, as previously reported [14] . Baicalin and zileuton at designated concentrations were continuously applied from 30 min before exposure to OGD or H 2 O 2 until the end of recovery or H 2 O 2 treatment.
Cell viability and death assay Cell viability was determined by MTT assay. Briefly, at the end of the experiments, the cells cultured on 96-well plates were incubated with 0.5 mg/mL MTT for 2 h at 37 °C. Then the supernatant was carefully removed, 100 µL of dimethyl sulfoxide was added into each well, and the absorbance of 490 nm of the MTT product formazan was determined on a Microplate Recorder (ELX 800, Bio-TEK instruments Inc, USA). The results are expressed as the percentage of control. Because the main type of OGD/recovery-induced cell death is necrosis [14] , we detected necrotic cells by propidium iodide (PI) staining. Cells were planted on glass coverslips. After treatment, cells were stained with 10 mg/mL of PI (Sigma-Aldrich) for 10 min at 37 °C. Then the cells were photographed under a fluorescence microscope (Olympus BX51) at excitation and emission wavelengths of 536 nm and 620 nm, respectively. The necrotic cells with red nuclei stained by PI were counted by a researcher who was blind to the treatments, and reported as percentages of total cells.
Western blotting analysis
Cells were collected and washed twice with ice-cold PBS, pH 7.4, then lysed for 30 min on ice in lysis buffer (100 mmol/L NaCl, 1% Nonidet P-40, 0.1% SDS, 1% deoxycholic acid, 10% glycerol, 1 mmol/L EDTA, 1 mmol/L sodium orthovanadate, 50 mmol/L sodium fluoride, 1 mmol/L phenylmethylsulfonyl fluoride, 10 µg/mL leupeptin, and 1 µg/mL aprotinin). Cell lysates were obtained by centrifugation at 12 000×g for 15 min at 4 °C. Protein samples (60 µg) were separated by 10% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. The membranes then were blocked by 10% fat-free milk and incubated with a mouse monoclonal antibody against phosphorylated www.chinaphar.com Li CT et al Acta Pharmacologica Sinica npg p38 (1:300) or a rabbit polyclonal antibody against p38 (1:300). Then they were incubated with horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (0.16 mg/L, Sigma-Aldrich) or HRP-conjugated goat anti-mouse IgM (1:3000, Zhongshan Biotechnology, Beijing, China) after repeated washing. Finally, the membranes were incubated with enzymatic chemiluminescence reagents and exposed on an X-ray film. The protein bands on the X-ray film were quantitatively analyzed with a laser densitometer (Ultro Scan XL, Pharmacia LKB Co, Stockholm, Sweden).
Measurement of CysLTs
Samples (100 µL) were removed from culture media after 2-h OGD and 0.5-h recovery and prepared according to previously reported method [12, 14] . Produced CysLTs (including LTC 4 , LTD 4 , and LTE 4 ) were measured by EIA kits according to the manufacturer's instructions and calculated as pg/mg protein. 
Measurement of intracellular ROS
Statistical analysis
Data are reported as mean±SD. Statistical comparisons were made by one-way ANOVA followed by Tukey's multiple comparisons tests or unpaired Student's t-tests to detect significant difference using SPSS 10.0 for Windows. P<0.05 was considered to be statistically significant.
Results
OGD/recovery-induced injury
Cell injury was aggravated in GFP-5-LOX-transfected PC12 cells after 2-h OGD and 24-h recovery. Baicalin (1-10 µmol/L) and zileuton (1-100 µmol/L) attenuated the reduction in cell viability after OGD/recovery in both GFP-and GFP-5-LOX-transfected PC12 cells ( Figure 1A and 1B) . In addition, baicalin (0.1 µmol/L) increased the cell viability in GFP-5-LOX-transfected PC12 cells ( Figure 1A) . As analyzed by PI staining ( Figure 1C) , baicalin (0.1-10 µmol/L) and zileuton (0.1-10 µmol/L) reduced OGD/recovery-induced necrosis in a concentration-dependent manner ( Figure 1D and 1E) . Baicalin (0.01 µmol/L) also reduced the necrosis in GFP-5-LOXtransfected PC12 cells ( Figure 1D ). These results confirm that OGD/recovery injury was more severe in GFP-5-LOX-transfected PC12 cells than in GFP-transfected cells and indicate that both agents exerted protective effects on OGD/recoveryinduced cell injury.
OGD/recovery-induced 5-LOX translocation
The transfected GFP-5-LOX was localized in cell nuclei, as determined by fluorescence microscopy. Specifically, GFP-5-LOX was translocated into the nuclear envelope after 2-h OGD and 2-h recovery (Figure 2A) . Baicalin (0.1-10 µmol/L) significantly inhibited GFP-5-LOX translocation in a concentration-dependent manner, but zileuton did not have this effect (Figure 2B and 2C) .
OGD/recovery-induced production of CysLTs After 2-h OGD and 3-h recovery (a peak time point for CysLT production), CysLT levels increased from 139.8±13.9 to 261.1±33.7 pg/mg proteins in the culture media. Baicalin and zileuton (10 µmol/L) significantly reduced OGD/recoveryinduced production of CysLTs. However, baicalin, but not zileuton, did not reduce the baseline level of CysLTs ( Figure  3 ). We did not measure CysLT levels after exposure to H 2 O 2 because the measurement failed in our recent study [14] .
OGD/recovery-induced ROS production and H 2 O 2 -induced injury
We measured intracellular levels of ROS by 2,7-dichlorofluorescin diacetate (DCF-DA) assay in the wild-type PC12 cells but not in the GFP-or GFP-5-LOX-transfected cells because the GFP fluorescence interferes with the fluorescence generated in the assay. After 2-h OGD and 0.5-h recovery (a time point when ROS production reached the maximum), ROS increased from 100%±11% to 412%±93%. Baicalin (0.1-10 µmol/L) reduced ROS production in a concentration-dependent manner, but zileuton did not affect ROS production ( Figure 4A and 4B).
To further determine the effects of baicalin and zileuton on oxidative stress-induced injury, we used the exogenous ROS H 2 O 2 to induce oxidative injury in PC12 cells. 
Phosphorylation of p38
Phosphorylation of p38 is induced by OGD/recovery (the maximum phosphorylation was induced by 2-h OGD and 1.5-h recovery) or H 2 O 2 (the maximum by 160 µmol/L for 20 min) [14] . Thus, we observed the effects of the agents on p38 phosphorylation after OGD/recovery and exposure to H 2 O 2 in such conditions. We found that baicalin (1−10 µmol/L), but not zileuton (1−10 µmol/L), significantly inhibited p38 phosphorylation induced by OGD/recovery and H 2 O 2 ( Figure 6 ).
Discussion
In the present study, we found that baicalin attenuated isch-www.nature.com/aps Li CT et al Acta Pharmacologica Sinica npg emic injury in PC12 cells, and this effect was partly mediated by oxidative stress-induced 5-LOX activation through the p38 MAPK pathway. These results support our recent findings that baicalin protects against OGD injury [13] . This protective action is mediated via inhibition of 5-LOX activity. As evidence supporting the involvement of 5-LOX in injury, both baicalin and the 5-LOX inhibitor zileuton inhibited the production of CysLTs and attenuated cell injury after exposure to OGD and H 2 O 2 . However, baicalin showed a different action from zileuton on 5-LOX activation. Specifically, baicalin inhibited 5-LOX translocation and activation by reducing ROS production after exposure to OGD and p38 phosphorylation after exposure to OGD and H 2 O 2 whereas zileuton directly inhibited 5-LOX enzymatic activity.
In the present study, we used PC12 cells transfected with GFP-5-LOX to visualize 5-LOX translocation and to enhance 5-LOX expression. The transfected GFP-5-LOX was primarily localized in nuclei [14, 27] . We previously demonstrated involvement of the ROS/p38 MAPK pathway of 5-LOX activation after ischemic-like injury as well as the two modes of action of 5-LOX inhibitors (anti-oxidative or direct inhibitors) in GFP-5-LOX-transfected PC12 cells [14] . Here we found that baicalin acts as an anti-oxidative inhibitor for 5-LOX. Unlike the typical 5-LOX inhibitor zileuton, baicalin did not inhibit baseline 5-LOX enzymatic activity but did inhibit the activity after OGD/recovery. Consistently, it has been reported that baicalin shows no inhibition of isolated potato 5-LOX [28] and non-stimulated rat cortical neurons [13] . Moreover, baicalin showed anti-oxidative activity because it reduced ROS production. These results indicate that baicalin might inhibit oxidative stress-induced 5-LOX activation rather than directly inhibit 5-LOX. Therefore, in addition to inhibiting 5-LOX activation induced by the elevated intracellular Ca 2+ via NMDA receptor activation [13] , baicalin also inhibits 5-LOX activation via the ROS/p38 MAPK pathway. In addition, there is crosstalk between NMDA-induced excitotoxicity and oxidative stress [29, 30] , and baicalin inhibits 5-LOX activation after NMDA receptor-mediated excitotoxicity [13] . Whether baicalin affects a common pathway of 5-LOX activation in both pathological processes requires further investigation.
The signaling family of MAPKs includes extracellular signal-regulated kinases (ERKs), c-Jun N-terminal kinases/ stress-activated protein kinases (JNK/SAPKs), and p38 enzymes [31] [32] [33] . As one type of cell stress, ROS activates the p38 MAPK signal pathway, but not the ERK and JNK pathways, after OGD-induced ischemic injury in PC12 cells [14] . In a human B-lymphocyte cell line and in human polymorphonuclear leukocytes, p38 MAPK is activated independently of Ca 2+ by chemical stress (sodium arsenite), osmotic stress (sorbitol, NaCl), heat shock or oxidative stress (H 2 O 2 , diamide), which leads to 5-LOX phosphorylation and activation [34, 35] . Recently, we found that the p38 inhibitor SB203580 inhibited 5-LOX activation induced by OGD/recovery and H 2 O 2 [14] . In the present study, baicalin inhibited p38 phosphorylation induced by both OGD/recovery and H 2 O 2 , supporting the conclusion that it inhibits 5-LOX activation through the ROS/p38 MAPK pathway. Our findings also confirm the role of p38 MAPK in cell stress-induced 5-LOX activation [3] . In the present study, we compared the effects of baicalin and zileuton. Zileuton is a specific 5-LOX inhibitor that chelates www.nature.com/aps Li CT et al Acta Pharmacologica Sinica npg iron at the active site with weak redox-active properties [36, 37] . Unlike baicalin, it did not possess substantial anti-oxidative activity, as shown in the present and previous studies [14] . In addition, zileuton did not inhibit p38 phosphorylation and 5-LOX translocation but did inhibit 5-LOX enzymatic activity and cell injury after exposure to OGD/recovery or H 2 O 2 . These findings indicate that baicalin inhibits 5-LOX activation partly through anti-oxidative activity and inhibition of the ROS/p38 MAPK pathway whereas zileuton directly inhibits 5-LOX activity.
Taking these results together, we conclude that baicalin is not a direct 5-LOX inhibitor but can inhibit oxidative stressinduced 5-LOX activation and the resultant cell injury in PC12 cells via inhibition of the ROS/p38 MAPK pathway in addition to inhibition of NMDA receptor activation, as shown in neurons [13] . Furthermore, baicalin exerts various effects [16] [17] [18] [19] and can protect against ischemic injury [20] [21] [22] [23] and inflammation [18, 22, 38] . One of the mechanisms of baicalin may include inhibition of 5-LOX activation in these disorders. 
